PDCD1 and malignant colon neoplasm: Furthermore, we intended to assess whether PNR could predict the prognosis of anti‐PD‐1‐containing therapy in patients with advanced solid tumor, such as gastric carcinoma, colon cancer, biliary tract carcinoma, or melanoma.